Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Thiotepa with Stem Cell Rescue in Refractory Malignancies
NCT00003173Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Sep 1997
- Primary completion
- May 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thiotepa in solid tumor, sponsored by Memorial Sloan Kettering Cancer Center. Started Sep 1997; status: completed.
02
Drugs
thiotepa
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00003173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003173.